SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the global launch of the Gibco™ CTS™ ...
As the rapid expansion of biologics continues, today’s high‑concentration injectables, prefilled syringes and cartridges, as ...
Offers Lifecore Key Access Point into Manufacture and Fill/Finish of Next-Generation Biotherapeutic Formulations with Potential to Deliver Significant Benefits to Patients Worldwide CHASKA, Minn., Oct ...
JERUSALEM, Feb. 25, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (SCNI) (Nasdaq: SCNI);("Scinai", or the "Company"), today announced that, following an additional review by the Israel ...
-New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug development- SPOKANE, Wash.–(BUSINESS WIRE)–February 12, 2025– Selkirk Pharma, Inc., ...
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results